ADVANCED SKIN CHELTENHAM PLASMA LIMITED
Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (72/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 105 (micro)Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 105 (micro)| Metric | 2024-11-30 |
|---|---|
| Total assets | £752 |
| Current assets | £9.5k |
| Net assets | £32 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
- • 3 accounts
- • 1 confirmation-statement
Corporate timeline (11 events)Click to expand
- 2026-02-27📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-12-01📄change-account-reference-date-company-current-shortenedaccounts · AA01
- 2025-11-28📄change-account-reference-date-company-current-extendedaccounts · AA01
- 2024-07-12📄accounts-with-accounts-type-dormantaccounts · AA
- 2023-09-25📄change-person-director-company-with-change-dateofficers · CH01
- 2023-09-25📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-07-12📄accounts-with-accounts-type-dormantaccounts · AA
- 2023-03-13📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2021-11-05🏢Company incorporatedAs ADVANCED SKIN CHELTENHAM PLASMA LIMITED
- 2021-11-05➕DANSON, Amber appointeddirector
- 2021-11-05📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mrs Amber Danson Individual · British · DOB 02/1980 · age 46 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 05/11/2021 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · GL postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 5 VALLEYS PHYSIOTHERAPY (GLOUCESTER) LIMITED→ 14096394 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| 5 VALLEYS PHYSIOTHERAPY (STROUD) LIMITED→ 14096391 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ACCOLADE SUPPORT AND CARE LTD→ 08489684 · est 2013 · no financials extracted | — | — | — | — | 13y | — | — |
| ACP FIRST LTD→ 14321365 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AD CAVE SOLUTIONS LIMITED→ 09611634 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| ADELFI CARE SERVICES LIMITED→ 12935232 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ADERYN HEARING LTD→ 15947729 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ADULARIA THERAPIES AND CONSULTANCY SUSSEX LIMITED→ 10382217 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| AK GYNAE LTD→ 13539400 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AL-FAPERIO LTD→ 08676510 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
| ALAGAO-GARCIA LIMITED→ 15230604 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ALBANY MEDICAL SERVICES LTD→ 16550144 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.